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Abstract
Decellularized extracellular matrices have been a growing area of interest in the
biomedical engineering fields of tissue engineering and regenerative medicine.As these
materials move toward clinical applications, the immune response to these materials will
be a driving force toward their success in clinical approaches. Fully digested
decellularized matrix constructs derived from porcine liver, muscle and lung were
created to test the adaptive immune response. Hydrogel characterization ensured that
the materials had relatively similar stiffness levels to reduce variability, and in vitro
studies were conducted. Each individual construct as well as a gelatin control were
plated with a co-culture of macrophages and T-cells to measure T-cell proliferation. In
addition standard markers of inflammation through qPCR were measured in the
macrophage group. Constructs were then placed into animals for 3 and 7 days in
addition to a second group that received constructs for 21 days before secondary
constructs were placed. These groups were then sacrificed following 3, 7 and 14 days
to measure the residual and memory-like response of the constructs. Our results
showed that t-cell proliferation was increased with decellularized constructs, particularly
in tissue with higher DNA content. In vivo, animals with secondary treatments showed
extended inflammatory response, driven by Th1 and Th17 polarization suggesting a
memory-like response due to recognition of peptides in the constructs from secondary
placements.
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Chapter 1 – Introduction and Significance

Significant strides have been made in the field of biomaterials and their application to
tissue engineering in recent decades. While new materials have proven useful over a
range of applications, many researchers are looking back toward the utilization of
natural tissue structures and proteins as a method of healing injury and regeneration.
Extracellular matrices are comprised of proteins produced by surrounding cells and
provide a variety of key functions necessary for the tissues including support, signaling
transduction and movement pathways. These proteins form a strict hierarchical
structure that can be difficult to replicate in vitro, yet are vital to the healthy functions of
a normal tissue. Extracellular matrices have become a popular biomaterial source for
the development of novel tissue engineering and regenerative medicine approaches to
a variety of conditions including cardiac, muscle and skin injuries. To apply these
materials to a clinical setting, processes must be used to remove all cells and danger
signals that could induce a negative immune response in the affected patient. These
processes range in a variety of physical, chemical and enzymatic methods which all can
greatly affect the mechanical and chemical properties of the matrix proteins following
treatment. Careful process selection is necessary in order to have a final extracellular
matrix product for the particular application a researcher or clinician needs. Extracellular
matrix can be broken down in a more gentle method in order to maintain the strict
protein structure seen in living tissue, or broken down more indiscriminately in order to
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develop gels or novel structures while still maintaining similar protein content, albeit in a
different structure.
Extracullar matrix constructs consisting of fully broken down proteins have become a
popular tool for research methods and potential clinical solutions. Through the utilization
of the same protein content found in natural extracellular matrix, gel constructs have
become adaptable applications for in vivo and in vitro studies for tissue engineering
approaches. Stem cell research in particular has looked toward decellularized
extracellular matrix to influence differentiation of the tissue or cell of choice through
direct contact with the naturally occurring proteins and growth factors. These studies
have shown promise in the ability of extracellular matrix to influence cells differentiation,
and promote growth of specific tissue sets dependent on the extracellular matrix
proteins introduced. These methods have even made the step toward clinical
applications in areas such as skin regeneration, and future studies show promise to the
beneficial capabilities of these matrix proteins.
While in vitro and in vitro studies have shown promise, the effect of the indiscriminate
breaking down of matrix proteins on the immune system has not been fully elucidated.
Studies have shown that the extracellular matrix proteins may not have significant
inflammatory effects on the innate immune system [1], however extensive research into
the effect these protein constructs have on the adaptive immune system has not been a
primary focus. The adaptive immune response occurs during and following the initial
cleanup, where the innate immune system collects these degraded proteins and
presents them to the adaptive immune system as a way to develop antibodies. Antibody
production introduces further inflammation, and is the building blocks to the memory-like
2
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system the body can deploy. With the small peptides and proteins from the extracellular
matrix being collected in the high-inflammatory environment of injury sites, the adaptive
immune system could collect these naturally found proteins and develop antibodies
against them. This is generally the method that auto-immune diseases attack native
tissue, usually due to a genetic defect in the protein. When the immune system
recognizes these native proteins or peptides and antibodies for them are produced,
increased inflammation at these proteins could occur. Further studies into the adaptive
immune response to fully deconstructed decellularized extracellular matrices are
needed to elucidate the interaction of the immune system with these broken down
proteins.

3
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Chapter 2 – Specific Aims

The specific aims of this project are to elucidate the interaction between fully
digested decellularized extracellular matrix constructs and the adaptive immune
response. The aims are split into an in vitro and in vivo aim respectively.
1.) In vitro - The objectives of the in vitro aim are to characterize the decellularized
matrices to be used in the study and determine the immune response in vitro.
Differences in each of our target tissue of interest may create differences in immune
response. We hypothesize that digested decellularized matrices will influence
macrophage and T cell activation.
2.) In vivo- The objectives of the in vivo aim are to characterize the decellularized
matrices to be used in the study and determine the immune response in vitro.
Differences in each of our target tissue of interest may create differences in immune
response. We hypothesize that digested decellularized matrices will influence
macrophage and T cell activation.
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Chapter 3 - Background

3.1 Biomaterials
As medical and scientific advances continue, novel materials are being utilized to
treat new problems or challenges in human health. The use of materials in treating
human condition has been widely applied for centuries but with a greater understanding
of mechanisms of disease and injury, new materials are being applied in hopes to find
cures or methods of regeneration for these diseases. Biomaterials can range across a
wide variety of materials, from metals and ceramics to polymers dependent on the
needs of the affliction [2]. For example, in dental and bone applications metals or
ceramics fulfill the necessary mechanical properties while eliciting a relatively low
immune response [3]. In the case of organ damage or failure, novel replacement
materials must be able to fulfill multiple criteria including function while maintaining a
low toxicity to reduce the immune response. These biomaterials can be utilized for a
range of functions including tissue regeneration, drug release or functional tissue
replacement. The success of these biomaterials is dependent on the ability to succeed
in its primary function. In the case of bone and dental implants, the material must be
able to undergo continuous stress while maintaining the integration at the site of
implementation without failure [4], [5]. For drug delivery hydrogels, the biomaterial must
be able to maintain its structure such that the delivery molecules can be released over
an extended time at a set rate [6]. In the case of organ failure and replacement, novel
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materials are being studied in hopes of developing a method for increasing the function
in a diseased state, or even potential regeneration of the tissue of interest.
While success of a biomaterial is primarily dependent on the ability to function,
many factors can lead to the failure of the implant. Failure of an implant can lead to
subsequent apoptosis of surrounding tissue, as well as buildup of fibrotic tissue and a
limitation on organ function [7]. To prevent implant failure, the material must be able to
maintain a microenvironment conducive to tissue function, including maintenance of
immune system balance. In the case of organ transplantation, the host must be
immune-compromised to reduce the risk of Graft-versus-Host Disease (GvHD). In the
case of GvHD, the host immune system may recognize the transplanted tissue as
genetically dissimilar, leading to subsequent attack by the host immune system [8]. This
in turn leads to tissue apoptosis and an influx of pro-inflammatory factors that are not
conducive to tissue function or survival.
One biomaterial that is gaining interest as a treatment option is the utilization of
decellularized matrix tissue to mimic the organ of interest as well as facilitate the
regrowth of tissue [9], [10]. Current treatments being used in a clinical setting primarily
include autologous bone matrix, acellular skin treatments for burn victims and acellular
heart valve procedures known as the Ross procedure [11]–[13]. With the major
reduction in cells, the risk of host immunity recognizing the tissue as foreign is reduced.
While the decellularized matrix alone is not capable of functioning as the replacement
tissue there is hope that the scaffold of the tissue containing the similar extracellular
components to its target treatment could lead to cell infiltration and regrowth. Due to
their high variability in source, as well as the ability to utilize decellularized tissues of
6
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interest as a treatment option, decellularized matrices have become a biomaterial of
choice in current biomedical research.

3.2 Decellularized Extracellular Matrices
Decellularized matrix and matrix components are becoming increasingly popular
tools in research and clinical settings for numerous applications. The properties of the
decellularized matrix is primarily dependent on the components of the extracellular
matrix of the tissue of origin. In the case of skin, the primary proteins are collagen type I
and elastin, which provide the tissue with the mechanical properties to stretch and
undergo large deformation. Cartilage however is primarily proteoglycan and collagen
type I and II to allow it to provide the dampening capabilities for joints. The
decellularized matrices of each of these tissues would therefor provide differing
mechanical properties and functions for their respective treatments.
There are physical and chemical processes that effect the composition of the
decellularized matrices following processing. The most common physical treatment
methods to remove cellular components include rapid temperature change through
freezing and electrical disruption. Rapid freezing leads to microcrystal formation in the
cell membrane, leading to effective lysing of the cell. One other aspect of the freezing is
that larger crystals can form, which can alter the conformation of the extracellular
proteins allowing for changes in porosity to occur. Applied electrical pulses can disrupt
the channels in the cell membrane causing an ion unbalance and subsequent cell
apoptosis.
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Chemical processes include washes of the tissue with ionic or non-ionic
detergents. Ionic detergents such as sodium dodecyl sulfate (SDS) efficiently lyse cells
and allow for soluble intracellular components to be rinsed away. Subsequent washes
with acids and endonucleases break down nucleic acids and solubilize them to be
removed with further washing. Non-ionic detergents such as Triton X-100 effectively
disrupt the lipid-lipid interactions in cell membranes, leading to effective lysing and cell
apoptosis. While these treatments are effective at cellular removal, they can disrupt the
protein structure [14]. SDS in particular has shown to bind and remove
glycosaminoglycans (GAGs) and other proteoglycan structures [15]. This can effectively
change the protein composition of the extracellular matrix in comparison to the native
tissue, especially in tissues with high levels of GAGs such as cartilage or skin.
Enzymatic treatments can also effectively decellularize tissues. In particular
endonucleases are extremely effective at breaking down genetic content following cell
lysing. Trypsin has also shown to be an effective enzymatic treatment for cell removal
[16]. Due to the protein-cutting nature of enzymes, many enzymes can affect the protein
structure of the remaining extracellular matrix. In treatments or studies that do not
require intact protein structures, enzymes can provide efficient decellularization. In
addition, collagenase and pepsin are enzymes that breakdown the extracellular matrix
entirely, ensuring removal of cells from the entirety of tissues as well as tunable
breakdown of protein structures [17].
Due to the wide variety of applications specified decellularization processes can be
utilized to ensure the post-treatment matrices contains the necessary parameters.
3.3 Innate Immune Response
8
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Immune response to these biomaterials can range across a spectrum dependent
on the innate immune response reaction. The initial response to any sort of implanted
biomaterial can dictate the subsequent immunological reaction, which can drive healing,
fibrosis or tissue death [18]. These “first responders” include tissue-resident
macrophages,

neutrophils

natural-killer

cells

and

dendritic

cells.

Phagocytic

macrophages and dendritic cells phagocytize pathogens or danger signals in the area
and influence the rest of the immune system with signaling [19]. Danger signals include
nuclear or cytosolic proteins that can be produced by damaged tissues and cells that do
not undergo the standard apoptosis methods. Macrophages and dendritic cells
phagocytize these biomolecules and can undergo a phenotype change toward a proinflammatory response, producing cytokines such as TNFα, IL-1B and IL-6 that
exacerbate the immune response [19]. Generally, activated macrophage phenotype is
characterized by a pro-inflammatory response (M1), anti-inflammatory (M2) or naïve
(MΦ) phenotype [20]. Pro-inflammatory macrophages are generally activated by
pathogens, however in the presence of Danger Signal Molecules similar proinflammatory responses can occur. Upon activation, macrophages can communicate
with

other

innate

and

adaptive

immune

cells

through

cytokine

microenvironment conditioning as well as antigen-presentation.

production,

Pro-inflammatory

activation leads to interleukin (IL) release which further recruits immune cells to the area
prolonging the inflammatory response. Anti-inflammatory activation leads to production
of cytokines which help control the immune response while also recruiting stem cells to
promote healing. While convention dictates these states as the primary phenotypes of
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macrophage activation, in reality the response is more along a gradient where immune
cells may not fall directly into one of the phenotypes.
Decellularized extracellular matrices can induce a response from the innate
immune system that ranges from inflammatory to anti-inflammatory [21], [22]. Studies
have shown differences in response dependent on the matrix purity, protein structure as
well as mechanical properties. While the decellularized process removes the majority of
cellular and genetic components, there can still be residual material which can lead to
danger signaling in the innate immune system [23]. Recognition of these signals
through Toll-like receptors (TLR) can lead to a signaling cascade producing a proinflammatory response and the presentation of antigens. In addition to RNA and DNA,
proteins and free cytokines can induce the same danger signal pathway in the innate
immunity.
3.4 Adaptive Immune Response
In addition to stimulatory factor production, macrophages and dendritic cells also
act as antigen presenting cells (APCs). Antigen presentation is one of the primary forms
of communication between the innate and adaptive immune response. The adaptive
immune system is comprised of cells from the lymphocytic lineage, T cells and B cells.
These cells can bind to the presented antigens leading to activation. Depending on the
type of antigen, different T cell activations can occur. Major-histocompatibility complex
type I (MHC I) antigens generally are presented by APCs to denote whether the cell is
foreign versus self. This can lead to an activation of CD8+ cytotoxic T cells, which attack
foreign bodies and virus infected cells [24]. Major-histocompatibility complex type II
(MHC II) antigens lead to activation of immunomodulatory CD4+ T helper cells. These
10

Kegan Sowers

cells produce a variety of inflammatory and anti-inflammatory factors that can either
prolong inflammatory response or attenuate it. T helper cells are commonly divided into
four subsets, though continuing studies are showing there may be a more robust
phenotypic layout [25], [26]. The four most prevalent subsets include type 1 helper cells
(Th1), type 2 helper cells (Th2), type 17 helper cells (Th17) and T regulatory cells
(Treg). Th1 cells produce interferon gamma (IFN-γ), a cytokine that promotes
inflammation through activation of other innate and adaptive immune cells [27].
Typically released in bacterial or viral infection, IFN-γ activates macrophages toward the
M1 phenotype increasing phagocytic activity and increasing CD4+ T cell activation
through a positive feedback loop [28]. Th2 cells secrete anti-inflammatory factors IL-4
and IL-13, which reduce macrophage activation and promote a more naïve lymphocytic
phenotype [29]. Th17 cells release stimulatory interleukin 17 (IL-17), as well as other
stimulatory cytokines including IL-21 and IL-22 [30]. IL-17 has been shown to be a
regulator of the pathogenesis of numerous auto-immune disorders as well as effective
stimulators of B-cell and T-effector memory cells [31]. Tregs are known as being
modulators of inflammation by releasing IL-10, which has shown to reduce inflammatory
phenotype in the innate immune cells [32].
B cells are the primary cells associated with the humoral immunity. B cell
receptors bind to antigens, which they can then internalize through endocytosis before
producing an MHC II antigen to present to T cells. Upon activation, CD4+ T helper cells
then produce a positive feedback loop through stimulatory cytokine production leading
to the rapid proliferation of these B cells. These B cells can activate become plasma
cells which begin producing antibodies for this specific antigen allowing for natural killer
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cells and macrophages to bind and phagocytize [33]. In addition, some of the B cells
may stay dormant, producing the effective “memory” to the antigen to be activated again
when encountered [34]. While typically thought of as primarily pathogen specific, B cells
can produce antibodies for tissue specific proteins and peptides as well as potentially
danger signals. These reactions form the basis for the pathogenesis of some
autoimmune disorders [34], in which tissue-specific antigens are taken by the immune
system, and antibodies for these antigens are produced leading to the attack of native
tissue by the immune system.

12
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Chapter 4 – Aim 1
Biomaterial Characterization and In Vitro Immune Response
Introduction
Decellularized matrices undergo many different processes to form the finalized
material to be utilized in research or clinically. The different process can alter the
physical and chemical composition of the decellularized matrix. While we focus on the
utilization of digested gels, the overall mechanical properties can be adjusted with a
backbone structure, in our case Methacrylated Gelatin (GelMA). Differences in stiffness
can influence the immune response, as can the presence of danger signals. To
determine the effectiveness of the decellularization process, DNA quantification can
measure the relative DNA levels before and after the decellularization process. The
objectives of this aim are to characterize the decellularized matrices to be used in the
study and determine the immune response in vitro. Differences in each of our target
tissue of interest may create differences in immune response. We hypothesize that
digested decellularized matrices will influence macrophage and T cell activation.
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Materials and Methods
Extracellular matrix processing
Extracellular matrices were prepared using a modified method of Reing et al.
[35], altering only two wash durations. Briefly, liver, lung and muscle pieces from a
porcine animal model were transferred into Erlenmeyer flasks and underwent a series of
chemical and enzymatic washes on an orbital shaker at 250 rpm. These consisted of
three 2-h washes with 0.25% trypsin EDTA to provide thorough washing; three 15-min
washes in deionized (DI) water; and one 15-h wash in 70% ethanol. This was followed
by one 15-min wash in 3% hydrogen peroxide in DI water; two 15-min washes in DI
water; and one 6-h wash in 1% Triton X-100 in EDTA/Trizma; and one 15-h wash in
fresh 1% Triton X– 100 in EDTA/Trizma. The cartilage matrices were then washed three
times for 15-min in DI water, followed by a 2-h wash in 0.1% peracetic acid (PAA)/4%
ethanol, two 15-min washes in phosphate buffered saline (PBS), and two 15-min
washes in DI water. Resulting pieces were frozen at 20 C for subsequent lyophilization
before utilization in in vitro and in vivo testing.
GelMA synthesis
The detailed experimental procedure has been described previously [36]. In
short, type A gelatin derived from porcine skin tissue was dissolved in calcium and
magnesium free phosphate buffer solution, and the pH was adjusted with 5 M sodium
hydroxide or 6 M hydrochloric acid. Subsequently, MAA (94%) was added dropwise to
the gelatin solution under magnetic stirring at 500 rpm while maintaining 60° C. The
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reaction proceeded for 3 h, and then the pH was readjusted to 7.4 to stop the reaction
by quenching with phosphate buffer solution. After being filtered, dialyzed for 7 days
in RO water, and lyophilized, the samples were stored at −20 °C until further use.
Formation of ECM gels
Therefore, ECM hydrogels were created using a modified version of the method
of Freytes et al. [37]. Processed lung, liver and muscle fragments (approximately 2 mm
x 2 mm) were frozen at 20 C overnight before lyophilization for 24 h. Lyophilized tissue
was digested with 30 mg/mL pepsin in 0.01 N HCl for 48 h at RT to make ECM digests
at a concentration of 10 mg (dry weight) per mL solution. ECM digest was stored at 20
C until gels were created. ECM digests were adjusted to physiological pH in PBS with
0.01 N NaOH, to form matrix gels with a final concentration of 6 mg (dry weight)/mL. 5%
GelMA was added to the ECM gels to aid in gelation and to maintain an approximately
equivalent stiffness level between all the groups. ECM/GelMA solutions were sterilized
under UV light for approximately three hours before continuing the experiment. 0.05%
LAP photoinitiator was added to the ECM gels. The matrix gels (500 µL) were then
coated on 24-well plates or prepared for surgery in syringes. ECM digests were allowed
to gel for 5 minutes under 405 nm Blue Light. Cartilage matrix gels were then hydrated
with 500 µL Mg2+ and Ca2+-free PBS (Life Technologies, Carlsbad, CA, USA) for 1 h.
PBS was then aspirated before cell culture experiments began.

Hydrogel Rheology
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One milliliter of pre-polymer ECM pre-gel and GelMA solution mixed with .05%
weight/volume Lithium Phenyl(2,4,6-trimethylbenzoyl) phosphinate (TCI America) was
pipetted into a two centimeter mold. Samples were then exposed to 9.6 mW/cm2 Blue
light 405 nm for 180 seconds. Samples were then removed from the petri dish and
tested using a TA Instruments Discovery HR-3 model rheometer. Samples were tested
under conditions of an amplitude sweep from .01 to 10% strain at a frequency of 1
rad/s. In addition, a frequency sweep from .1 to 10 rad/s was conducted at a constant
strain of .05%. All tests were conducted at 37°C to best represent physiological
temperature.
Cell Isolation and culture
Primary macrophages were isolated from femurs of 8-12 week-old female
C57BL/6 mice (The Jackson Laboratory, Bar Harbor, ME) under VCU IACUC approval
based on previously established protocols. Briefly, bone marrow cells were flushed from
the femurs using Dulbecco's phosphate-buffered saline (Life Technologies, Carlsbad,
CA). Red blood cells were removed from flushed bone marrow by addition of ACK
Lysing Buffer (Quality Biological, Inc., Gaithersburg, MD). Cells were counted (TC20™
Automated Cell Counter, Bio-Rad Laboratories, Hercules, CA) and plated in a 175 cm2
flask at a density of 500,000 cells/mL in 30mL RPMI 1640 media (Life Technologies)
supplemented with 10% fetal bovine serum (Life Technologies), 50U/mL penicillin-50
µg/mL streptomycin (Life Technologies), and 30ng/mL macrophage colony-stimulating
factor (M-CSF, PeproTech, Rocky Hill, NJ). Cells were cultured at 37°C, 5% CO2, and
100% humidity. Fresh media supplemented with M-CSF was added after four days.
After seven days of exposure to growth factors, macrophages were passaged with
16
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Accutase (Life Technologies) at room temperature for 1 hour and seeded onto ECM
hydrogel coated plates for experimentation.
Primary T cells were isolated from spleens removed from the same 8 week-old
female C57Bl/6 mice. Naïve CD4+ T cells were then separated by negative selection
using isolation columns (Milteny Biotec, San Diego CA). Briefly, spleens were crushed
between two sterilized microscope slides to release cells, and red blood cells were
lysed (ACK Lysing Buffer, Quality Biological, Inc.). A single cell suspension was
magnetically labeled using a cocktail of biotinylated monoclonal antibodies and antibiotin microbeads labeling agents to deplete non-CD4+ splenocytes. Untouched
isolated CD4+ T cells were then cultured in complete RPMI 1640 containing 10% FBS,
1% L-Glutamine, 1% penicillin-streptomycin, and 0.1% 2-mercaptoethanol and activated
for 48 hours in plates pre-coated with 5μg/mL anti-CD3e mAb (Biolegend) and treated
by 2μg/mL anti-CD28 to promote proliferation before being used in experiments.
In vitro Macrophage Activation
To compare macrophage activation on the different Ti surfaces, secreted factors
were quantified following 24 hours of culture. Differentiated macrophages were plated
on Hydrogel coated well plates at a density of 50,000 cells/cm 2. Media was removed
and levels of pro- (IL1β, IL6, and TNFα) and anti- (IL4 and IL10) inflammatory markers
for macrophage activation were measured by enzyme-linked immunosorbent assay
(ELISA) based on manufacturer’s protocol and normalized to cell number. Cell number
at was determined using DNA quantification assay and a standard curve plated with a
known protein quantity plated in serial dilution. DNA levels were quantified in cell lysates
using the Quant-iT™ PicoGreen dsDNA Assay Kit (Invitrogen, Life Technologies) as per
17
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manufacturer protocol. RNA was isolated from plated macrophages with TRIzol (Life
Technologies) following manufacturer’s instructions. Equal amounts (1000 ng) of RNA
were reverse transcribed into cDNA for each sample (High Capacity cDNA Kit, Life
Technologies). The resulting cDNA was used in real-time quantitative polymerase chain
reaction (qPCR) reactions using Sso Universal Probes Supermix (Bio-Rad, Hercules,
California) to measure mRNA quantities of pro and anti-inflammatory factors.
In Vitro Co-Culture Model
Interactions between T-cells and macrophages were examined using direct coculture experiments. In indirect co-culture experiments, macrophages were cultured on
Ti surfaces for 24 hours at a density of 50,000 cells/well and media with secreted
factors (conditioned media) were then collected and used to treat activated T-cells in a
separate 24 well plate. For direct culture experiments, macrophages were grown on
decellularized matrix hydrogels for 24 hours and then activated T-cells were added to
the culture in a 1:1 ratio. These cells were allowed to interact for an additional 24 hours
before media, and non-adherent T-cells were collected for analysis. To assess
proliferation, CD4+ T-cells were treated with carboxyfluorescein succinimidyl ester
(Yellow,

Molecular

Probes,

ThermoFisher)

during

the

direct

co-culture

with

macrophages. Activated T-cells cultured with CD3 and CD28 (+) and unactivated T-cells
cultured with only CD3 on GelMA were used as control groups. After 24 hours of
interaction, cells were collected and analyzed by flow cytometry. Changes in CD4+ Thelper proliferation were determined by flow cytometry using a CellTrace Yellow Cell
Proliferation Kit (ThermoFisher Scientific, Waltham, MA). Stained cell suspensions were
analyzed using the Guava® easyCyte 6-2L Benchtop Flow Cytometer (MilliporeSigma)
18
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instrument with a total of 10,000 events were measured with three replicates for each
measurement. Results were analyzed using guava Soft 3.1.1 InCyte software.
Statistical Analysis
A one-factor, equal-variance analysis of variance (ANOVA) was used totest the
null hypothesis that the group means are equal, against an alternative hypothesis that at
least two of the group means are different, at the α=0.05 significance level. Upon
determination of a p-value less than 0.05 from the overall ANOVA model, multiple
comparisons between the group means were made using the Tukey-HSD method. All
statistical analysis was completed using GraphPad V5 software.
Results and Discussion
Gel Rheology
Gel Rheometry conducted on the gel constructs was to ensure that the
stiffnesses of the matrices were consistent such that there was not a strong difference.
Differences in stiffness between matrix substrates have shown the ability to influence
macrophage activation, fibrosis and healing [38]. Rheometry results across a frequency
and amplitude sweep showed no significant differences between the GelMA group and
hydrogel constructs. All storage modulus values fell between 200 and 300 Pascals
(Figure 1), which is representative of extremely soft tissue such as brain tissue [39].
While precautions and testing can be conducted to ensure comparable mechanical
properties, even slight differences have been shown to influence macrophage activation
[40]. The stiffness provided allows for injection in in vivo studies, while maintaining its
structure over time without risky solubilizing.
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Figure 1: Storage modulus values for each decellularized matrices
treatment. 20 mm diameter pucks, 1 mL in volume of gel solution
was used for each rheometry puck.

DNA Quantification
To measure purity of the processed samples following treatment, DNA
quantification was conducted before and after processing to quantify DNA removal in
comparison to dry weight. Prior to decellularization, liver contained 70.415 ng/mg dry
weight DNA, 26.243 ng/mg dry weight DNA in lung tissue and 8.0738 ng/mg dry weight
DNA in muscle tissue. Following the decellularization process, 97-98% of all DNA
content was removed from the tissue as shown in Table 1. These values are
representative to those values found in literature and commercially [41], indicating that
while the prevalence of Danger Signals is still a concern, it does fall within the approved
range of acceptable values in research and industry. Microscopic image of pretreatment versus post-treatment shown in (Figure 3).
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Liver
Lung
Muscle

DNA pre-processing (ng/mg
dry weight)
70.415
26.243
8.0738

DNA post-processing (ng/mg
dry weight)
1.7061
0.4038
0.1152

Total Percentage
Reduction
97.58
98.46
98.57

Table 1: DNA content prior to and following the decellularization processing.

A

B

C

D

E

F

Figure 2: Microscopic imaging of Muscle, Lung and Liver
pre-processing (A,B,C) and post-processing (D,E,F)
respectively.

Macrophage Activations
Following 24 hours of culture, expression of both pro and anti-inflammatory
markers were measured by qPCR. No statistically significant changes in mRNA
expression of pro-inflammatory markers Il-6, Tnfα or Il-1β between the liver, lung and
muscle groups compared to the control (Figure 3). In addition, no statistical differences
were seen in the comparisons of the treatment groups.

Similarly, no statistically

significant changes in marker of anti-inflammatory Il-10 were seen. While on the surface
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Inflammatory mRNA Expression

Figure 3: Changes in mRNA expression in primary macrophages plated on protein
coated well plates (n=3). # p<0.05 vs control, @ vs Liver coating, & vs Lung coating.

these results may be surprising, many studies have shown that while danger signals
and exogenous peptides from decellularization processing can cause inflammation,
others have publicized immunomodulatory behavior by decellularized matrices [22],
[42]. Following proper decellularization procedure, and reducing residual DNA content
to a minimum, immune response can be reduced. Another potential explanation for the
reduced immune response relies on the later time point (24 hours) of termination of cell
culture experimentation. By 24 hours, macrophages may already be producing the pro
or anti-inflammatory cytokines, and expression of these markers may have been
reduced to closer to standard levels.
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Macrophage protein secretion drives further immune response by activation and
recruitment following activation in response to exogenous peptides or danger signals.
Significant differences in inflammatory cytokine production were seen following 24 hours
of macrophage culture on each of the decellularized matrix protein coated well plates
compared to control (Figure 4). Liver and muscle treatment groups showed the greatest
increase in pro-inflammatory cytokine TNFα production in comparison to the control.
Pro-inflammatory cytokine IL-6 was increased in all treatment groups, while IL-1β
secretion showed no statistical differences between the groups and the control. Antiinflammatory cytokines IL-4 and IL-10 secretion was increased significantly in all
treatment groups, with exception to IL-10 for the liver treatment with respect to the
control. Overall, each of the treatment groups did have an affect on the initial cytokine
secretion following direct plating on the decellularized matrices. Xenograft antigenicity
can affect the murine immune system through recognition of certain peptide
configurations as non-self or foreign material. In addition, residual DNA would increase
this immune system activation, in comparison to an allograft or autograft where
recognition of self would be more likely to occur.
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Inflammatory Cytokine Production

Figure 4: Changes in cytokine production from macrophages plated on ECM constructs (n=6). #
p<0.05 vs control, @ vs. Liver treatment, & vs. Lung treatment.

T cell activation
To determine the incidence of antigen presentation by macrophages,
macrophages and CD4+ T helper cells were co-cultured directly. Following 24 hours of
macrophage culture on each of the hydrogel coated plates, T cells were plated at a 1:1
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ratio and allowed 48 hours for proliferation. Direct interaction between the macrophages
and the T-cells on all treatment groups led to the ability to proliferate. Liver and muscle
groups showed the highest incidence of T cell proliferation (CFSE low) of the treatment
groups (Not Shown). GelMA and lung treatment T cells both showed the ability to
proliferate, but the groups with higher inflammatory profiles produced greater rates of
proliferation. This indicates that the decellularized matrix constructs are inducing
macrophage presentation of Major Histocompatibility Class II antigens capable of
activating CD4+ T helper cells which drive further adaptive immune response.
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Conclusion
Decellularized matrices are becoming a common tool for biomedical research
and clinical applications. Due to their variability in structure and function, decellularized
matrices of a multitude of tissue origins are being utilized to treat a variety of ailments.
When decellularizing a matrix, care must be taken in choosing the best process to meet
the scaffold function. Some studies focus on full tissue scaffolds, where full protein
structure is maintained in hopes of allowing for re-infiltration by stem cells, and
subsequent tissue regeneration. Other methods of decellularization utilize enzymes to
further break down the protein structures, to fully reduce DNA content from the native
tissue. In doing so, broken proteins may for peptide or protein configurations not
typically found in the area, particularly for allografted or xenografted decellularized
extracellular matrices. In our study, xenografted porcine tissue interacting with murine
cells did induce a slight immune response. The decellularized liver, lung and muscle
were all digested in pepsin prior to forming the ECM hydrogel construct, and as such
were able to control the stiffness of the materials even though the native tissue
stiffnesses varied greatly. The broken-down proteins could provide peptides that act as
antigens in the MHC II antigen presentation macrophages. When phagocytized along
with the remnant DNA and other danger signals, increases in TNFα and IL-1β lead to
further macrophage activation as well as lymphocytic activation. T cells would then be
activated, and from the MHC II antigen presentation, CD4+ T helper cell proliferation
would occur as discovered in the co-culture study for the treatment groups. While
inflammatory activation from decellularized matrices is not an entirely novel
phenomenon, the influence on the adaptive immune system has not been elucidated,
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and further studies will have to be conducted to confirm the mechanism of action for this
activation pathway. Since it has been shown to be capable of activating macrophages
and influencing the activation of CD4+ T helper cells, then could this activation via
antigen presentation lead to further influence in the adaptive immune system and
potentially a memory or auto-immune like response to these peptides? In clinical
translation, the utilization of decellularized matrices would typically be for a diseasestate patient or model. The addition of digested extracellular matrices in an immunecompromised system may lead to further presentation of digested proteins as antigens,
leading to an enhanced adaptive immune response. In particular, the presentation of
these antigens could lead to a memory or autoimmune-like response, particularly in
cases that may require multiple treatments.
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Chapter 5 – Aim 2
Decellularized Matrices Effect on the Adaptive Immune Response In
Vivo

Introduction
From the previous aim we found that digested decellularized matrices did affect
the immune response by macrophages, as well as activation of CD4+ T helper cells.
With the proteins broken down to peptides, phagocytotic cells can engulf these peptides
and present them as an antigen. This phenomena is more likely to occur if the likelihood
of being recognized as self

vs. non-self is increased, such as for xenografts. The

objective of this aim is to determine if the decellularized matrix constructs influence the
adaptive immune response in vivo, and if repeated treatments lead to a lengthened and
elevated immune response. When the adaptive immune response binds to antigens,
they can then begin recruiting other cells such as B cells to replicate and produce
antibodies for this antigen. In addition, B cells that contain the antibody can remain
dormant as a memory cell, such that when activated by the specified antigen, they
begin producing antibodies initializing the pro-inflammatory feedback loop. We
hypothesize that digested decellularized extracellular matrix constructs induce a proinflammatory response in vivo, and shift the adaptive immune response toward proinflammatory CD4+ subsets Th1 and Th17. In addition, repeated treatments of these
constructs will further initialize and lengthen the pro-inflammatory response.
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Materials and Methods
Animals and Surgical Procedure
For each study, 8 to 12-week female C57Bl/6 mice (The Jackson Laboratory, Bar
Harbor, ME) were used. Animal handling procedures were performed under the
approval of the Virginia Commonwealth University Institutional Animal Care and Use
Committee (Protocol: AD10001108). Surgeries were performed between 8am and 12pm
with mice randomly assigned to groups. 100 microliters of hydrogel sample were
injected into the right femoral medullary canal of mice via a medial parapatellar
arthrotomy as previously described [43]. Prior to procedures, mice were anesthetized by
inhalation of 5% isoflurane gas in O2 and weighed (weight range 19-22g). Legs were
prepared by shaving and cleaned with isopropanol and chlorhexidine. Mice were
maintained under anesthesia by isoflurane gas to effect during preparation and surgical
procedures. To place the hydrogel implant an 8 mm incision was made with a scalpel
over the distal side of the knee. The knee ligaments and patella were then moved aside
to expose the intercondylar notch of the femur. A 1 mm round dental burr was used to
penetrate into the bone and access the medullary canal. Extracellular matrix hydrogel
samples were then injected into the medullary canal. Three successful implants were
performed for each hydrogel type. After implant placement, periosteal tissue was
replaced and closed using resorbable sutures and surgical incisions closed with wound
clips. Animals were treated with 0.01mg/kg buprenorphine SR LAB prior to recovery
from anesthesia to relieve post-operative pain. Animals were monitored until initial
ambulation and every 24 hours for the first 3 days following surgery. Secondary surgery
animal groups were treated under the same protocol as previously mentioned following
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21 days after initial surgery. For secondary treatment groups and the 14 day post
surgery groups the staples were removed following 7 days post treatment. All animals
were single housed following surgical procedure, with standard 12-hour light dark cycle
and access to food and water ad libitum for the duration of the study. No signs of
infection were present in this study.
Flow Cytometry Analysis
Changes in local cell populations were quantified by flow cytometry of bone
marrow cells after 3, 7 or 14 days. Systemic changes were measured lymph nodes and
spleens. Prior to staining, Fc receptors were blocked by incubation with CD16/32
(BioLegend, San Diego, CA) and membranes permeabilized for transcription factor
staining. Macrophage populations were measured in the bone marrow as well as liver
with M1 and M2 positive antibody stainings [CD11b – FITC, CD86 (M1) – PE, CD206
(M2) – APC].The ratio of b-cell and t-cell population was determined in lymph and
spleens (T cell: PE-CD3, B cell: APC-CD29) (Biolegend). T cell populations were
compared in lymph nodes, spleen and bone marrow (PE-CD3, APC-CD4, FITC-CD8).
In addition T cell populations in the spleen and lymph nodes were identified by
antibodies against T-helper cell marker CD4 (APC-CD4, Biolegend), as well as
transcription factors of specific T cell populations [Th1 (PE-Tbet), Th2 (Alexa 488Gata3), Th17 (PE-RORγT, BD Biosciences), and Treg (Alexa 488-Foxp3)] (Biolegend).
Cells were fixed and permeabalized for intracellular staining using Foxp3 Transcription
Factor Staining Kit (eBiosciences, Thermofisher). Antibody concentrations were added
based on manufacturer’s protocol. Stained cell suspensions were analyzed using the
Guava® easyCyte 6-2L Benchtop Flow Cytometer (MilliporeSigma) instrument with a
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total of 10,000 events were measured with three replicates for each measurement.
Results were analyzed using guava Soft 3.1.1 InCyte software.
Circulating Inflammation
Serum was isolated from circulating blood collected 3, 7 and 14 days post
material implantation by cardiac puncture. Following Cytokine levels were quantified by
Enzyme-Linked immunoSorbant Assays (ELISAs) for pro-inflammatory (IL-6, TNF, IL1B, IL-17) and anti-inflammatory (IL-10) factors. Cytokine levels were analyzed and
normalized to protein per mL serum based off of the dilutions applied to collected whole
blood. Standard curves of the serial dilutions provided the method to quantify the
amplification when reading at 450 nm.
Statistical Analysis
A one-factor, equal-variance analysis of variance (ANOVA) was used totest the
null hypothesis that the group means are equal, against an alternative hypothesis that at
least two of the group means are different, at the α=0.05 significance level. Upon
determination of a p-value less than 0.05 from the overall ANOVA model, multiple
comparisons between the group means were made using the Tukey-HSD method. All
statistical analysis was completed using GraphPad V5 software.
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Results and Discussion
In Vivo Local Macrophage Activation
To assess the effect of the decellularized extracellular matrix constructs on the
local inflammatory microenvironment, macrophage activation was measured in the bone
marrow at the site of hydrogel injection. In our first study, GelMA, liver, lung and muscle
hydrogels were injected into the medullary cavity in one standard surgery. At three days
post-surgery surface markers for inflammatory macrophages (CD86+) were significantly
elevated in each treatment group in comparison to the GelMA and control groups, with
liver and muscle both increasing the highest (Figure 5). The GelMA group saw no
statistical difference in pro-inflammatory surface markers in comparison to the control.
By 7 days, CD86+ cells were still significantly elevated in the decellularized matrix
groups in comparison to the control and GelMA groups, though the percentage of
inflammatory macrophages were attenuated in each case. Anti-inflammatory (CD206+)
macrophages were elevated in each of the treatment groups including GelMA in
comparison to the control 3 days following surgery. By 7 days, anti-inflammatory
macrophages were still elevated, and have increased in comparison to the 3 day
counterpart . This would be as expected, where the macrophage polarization shifts over
time at the injury site from inflammatory (M1) to anti-inflammatory (M2) as the healing
process commences.
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7 Day

3 Day

1st Surgery Groups

Figure 5: Local changes in macrophage phenotype populations in the bone marrow
between single surgery treatment groups (n=3) at 3 and 7 days post-surgery.
Inflammatory macrophages (M1) denoted by CD11b+ and CD86+ selection while
Anti-inflammatory macrophages denoted by CD11b+ and CD206+ selection. #
p<0.05 vs control, @ vs. GelMA treatment, & vs. Liver treatment, % vs. Lung
treatment.

In our second study, GelMA, liver, lung and muscle hydrogels were injected into
the medullary cavity over two separate surgery procedures. Following the first surgery,
the animal models were allowed to heal for 21 days post treatment, before undergoing
the secondary surgery. This methodology helps highlight the memory response of the
adaptive immune system. Surface markers for inflammatory and anti-inflammatory
macrophages were quantified at 3, 7 and 14 days post secondary surgery to monitor the
inflammatory reaction. At 3 and 7 days post secondary surgery, as seen in the single
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surgery treatment groups, the inflammatory macrophage phenotype was significantly
increased in comparison to the GelMA and control group counterparts (Figure 6). In
contrast, the GelMA groups showed significantly increased presence of inflammatory
macrophages at 3 and 7 days post secondary surgery in comparison to the control,
indicating that there is some inflammation associated with being a secondary surgery in
comparison to the single surgery groups. At 14 days post-surgery, the difference
between the GelMA and control group has been reduced to be no longer statistically
significant, which would suggest that by 14 days post secondary surgery the
inflammation has been resolved; however, the three extracellular matrix groups while
reduced still maintain a significantly elevated level of M1 activation in comparison to the
GelMA and control groups. This seems to suggest that while the inflammation may have
been resolved following the first surgery after 21 days, the re-introduction of the
decellularized matrices influenced the immune system to remain in a longer
inflammatory state, presumably due to adaptive immunity.
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14 Day

7 Day

3 Day

2nd Surgery Groups

Figure 6: Local changes in macrophage phenotype populations in the bone marrow
between secondary surgery treatment groups (n=3) at 3, 7 and 14 days postsurgery. Inflammatory macrophages (M1) denoted by CD11b+ and CD86+ selection
while Anti-inflammatory macrophages denoted by CD11b+ and CD206+ selection. #
p<0.05 vs control, @ vs. GelMA treatment, & vs. Liver treatment, % vs. Lung
treatment.
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In Vivo Cytokine Secretion
In addition to macrophage activation, systemic inflammatory profile can be
quantified by measure of cytokine levels found in whole blood. Pro-inflammatory (IL-1β,
IL-6, TNFα and IL-17) cytokines and anti-inflammatory (IL-10) cytokine levels were
measured through Enzyme-Linked Immunosorbant Assays, and normalized to a
standard provided. In single surgery groups, decellularized matrix treatment groups had
significantly elevated levels of all pro-inflammatory cytokines at 3 and 7 days post
surgery (Figure 7). From 3 to 7 days, these inflammatory cytokine levels are reduced,
suggesting that by 7 days inflammation has run its course, and a more naiive state of
inflammation is in place. In the secondary surgery groups, we see extremely elevated
levels of pro-inflammatory response at 3 days post surgery. Pro-inflammatory cytokine
production of IL-1β, IL-6, TNFα and IL-17 all continue to rise through 7 days post
surgery, and begin to attenuate by 14 days post surgery (Figure 8). This suggests a
highly elevated as well as lengthened inflammatory response in the secondary surgery
groups due to recognition of antigens. This leads to increased Th17 expression and
enhanced IL-17 cytokine production.
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Serum Cytokine Levels 1st Surgery

Figure 7: Changes in systemic cytokine levels in circulating plasma for single surgery groups
at 3 and 7 days post-surgery (n=3). # p<0.05 vs control, @ vs. GelMA treatment, & vs. Liver
treatment, % vs. Lung treatment.
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Serum Cytokine Levels 2nd Surgery

Figure 8: Changes in systemic cytokine levels in circulating plasma for secondary surgery
groups at 3 and 7 days post-surgery (n=3). # p<0.05 vs control, @ vs. GelMA treatment, &
vs. Liver treatment, % vs. Lung treatment.
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Local T cell activation
To measure the influence of the extracellular matrix treatments on the local
adaptive immune system response, T cell populations were quantified in the bone
marrow 3 and 7 days after our primary surgery group. 3 days following the primary
surgery, both CD4+ T helper cells and CD8+ Cytotoxic T cells were elevated in
decellularized matrix treatment and GelMA treatment in comparison to the control
(Figure 9). By 7 days post treatment, CD4+ cells in GelMA treatment groups were no
longer significantly elevated in comparison to the control groups. The three
decellularized matrix groups all maintained significantly elevated T helper cell incidence
at 7 days post surgery compared to the GelMA and control group suggesting that there
is an elevated presence of MHC II antigen presentation in the area activating and
proliferating CD4+ T cells.

7
Day

3
Day

1st Surgery Bone Marrow Groups

Figure 9: Local changes in T cell populations in the bone marrow between single
surgery treatment groups (n=3) at 3 and 7 days post-surgery. Th signifies T helper
cell groups (CD4+) while Tc signifies cytotoxic T cell (CD8+) groups. # p<0.05 vs
control, @ vs. GelMA treatment, & vs. Liver treatment, % vs. Lung treatment.
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In our secondary surgery groups, similar trends are followed as in the primary
surgery study. At 3 and 7 days post surgery, decellularized matrix groups have severely
elevated levels of CD4+ T helper cells and CD8+ Cytotoxic T cells (Figure 10). While
cytotoxic T cells maintain elevated expression throughout in all groups, this can be an
indicator of the pro-inflammatory subset of CD4+ cells being elevated. When activated
to the Th1 subset, interferon-γ secretion leads to the proliferation of CD8+ T cells. At 3
days post surgery the GelMA treatment group also is significantly elevated T-helper
cells compared to control. This activation is no longer statistically significant by day 7
and 14. All three decellularized matrix treatment groups maintain elevated levels of
CD4+ T helper cells at 7 and 14 days post-surgery suggesting a prolonged T helper
response due to the peptides or danger signals present in the decellularized matrix, and
those antigens being potentially “remembered” by the adaptive immune response.
When comparing the percentage of local T cells positive for CD4+ in the bone marrow
of the secondary surgery groups to primary surgery groups there is a trend toward
increased activation in secondary treatments.
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14 Day

7 Day

3 Day

2nd Surgery Bone Marrow Groups

Figure 10: Local changes in T cell populations in the Bone Marrow
between treatments in the secondary surgery groups (n=3) at 3, 7 and 14
days post-surgery. Th signifies T helper cell groups (CD4+) while Tc signifies
cytotoxic T cell (CD8+) groups # p<0.05 vs control, @ vs. GelMA
treatment, & vs. Liver treatment, % vs. Lung treatment.

Local Adaptive Immune Response
To measure the local adaptive immunity, B cells (Figure 13) and CD4+ subgroups were stained in the right lymph node nearest the surgery site. Similarly to the
local response, T cell activation was measured in the right lymph nodes as well. In a
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similar trend as previously reported, CD4+ and CD8+ T cell populations were
significantly elevated in the decellularized matrix groups in comparison to the GelMA
and control groups (Figure 11). These elevated levels were maintained in the lymph
node through 3 and 7 days post surgery for single surgery groups. Secondary surgery
groups followed a similar trend (Figure 12). At 3 and 7 days post surgery, CD4+ cells
were extremely elevated, reaching levels extensively higher than in the primary surgery
group. This could be due to communication with antibodies produced by t effector or B
cells which constitutes the memory response of the adaptive immunity.

7 Day

3 Day

1st Surgery Right Lymph Node

Figure 11: Local changes in T cell populations in the right lymph node between single
surgery treatment groups (n=3) at 3 and 7 days post-surgery. Th signifies T helper cell
groups (CD4+) while Tc signifies cytotoxic T cell (CD8+) groups. # p<0.05 vs control, @
vs. GelMA treatment, & vs. Liver treatment, % vs. Lung treatment.
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14 Day

7 Day

3 Day

2nd Surgery Right Lymph Node

Figure 12: Changes in T cell populations in the right lymph nodes between secondary
surgery treatment groups (n=3) at 3, 7 and 14 days post-surgery. Th signifies T helper
cell groups (CD4+) while Tc signifies cytotoxic T cell (CD8+) groups. # p<0.05 vs control,
@ vs. GelMA treatment, & vs. Liver treatment, % vs. Lung treatment.
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To look into more specifically how the T helper cells are influencing the immune
response and local microenvironment, T helper cell populations were stained for four
primary subsets: Th1, Th2, Th17, and Treg. In the first study consisting of one single
surgery, Th1 and Th17, classically considered pro-inflammatory T helper cell subsets
see significant increases in activation in all decellularized matrix groups in comparison
to the GelMA and control. This is maintained through seven days in all groups, with Th1
levels in the lung treatment group reducing lower levels, though maintain a significant
increase compared to the control. This would suggest that the hydrogel constructs, as
well as the surgeries themselves would shift the CD4+ T helper cells toward a proinflammatory response via Th1 and Th17 activation (Figure 14). Generally this response
then seems to shift back toward anti-inflammatory as Treg subpopulations increase
dramatically between day 3 and 7 post surgery, and Th17 levels begin to drop off.
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1st Surgery Right Lymph Node
3 Day

7 Day

Figure 14: Changes in T helper cell populations in the lymph node between
single surgery treatment groups (n=3) at 3 and 7 days post-surgery. Following
CD4% selection, transcription factor staining for Tbet (TH1), Gata3 (TH2), RORγt
(TH17) and Foxp3 (Treg) identified T helper cell subsets. # p<0.05 vs control, @
vs. GelMA treatment, & vs. Liver treatment, % vs. Lung treatment.
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In the secondary surgery groups, T helper cell populations follow a similar trend
as was discussed previously though delayed. At 3 and 7 day post secondary surgery,
pro-inflammatory Th1 and Th17 subsets are increasing dramatically and reaching their
peak at 7 days (Figure 15). Previously in single surgery groups, extracellular matrix
treatment groups reached their highest increase at day 3, and begin reducing with
elevated Treg ctivation at 7 days. For secondary surgery groups, pro-inflammatory T
helper cells did not begin attenuating until day 14, at which point Treg activation is
increased dramatically. This overall trend suggests that the secondary treatment groups
are extending the pro-inflammatory response, and shifting the CD4+ T helper cells
primarily toward Th1 and Th17 phenotypes. The Th1 phenotype is the prime driver of
the positive inflammatory feedback loop through interferon-γ secretion. Th17 is
classically known as a link between adaptive and immune systems, and a driver of the
pathogenesis of multiple autoimmune disorders [44], [45]. The increased prevalence of
pro-inflammatory Th17 cells also induce the activation and proliferation of B cells
(Figure 13). These B cells can then provide antibodies to the antigen or go dormant as
memory cells.

46

Kegan Sowers
2nd Surgery Right Lymph Node
3 Day

7 Day

14 Day

Figure 15: Changes in T helper cell populations in the lymph node between secondary surgery treatment groups
(n=3). Following CD4% selection, transcription factor staining for Tbet (TH1), Gata3 (TH2), RORγt (TH17) and Foxp3
(Treg) identified T helper cell subsets. # p<0.05 vs control, @ vs. GelMA treatment, & vs. Liver treatment, % vs. Lung
treatment.
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2nd Surgery Right Lymph Node

14 Day

7 Day

3 Day

1st Surgery Right Lymph Node

Figure 13: Changes in B cell populations in the right lymph node between single and
secondary surgery treatment groups (n=3) at 3, 7 and 14 days post-surgery through
CD19+ staining selection. # p<0.05 vs control, @ vs. GelMA treatment, & vs. Liver
treatment, % vs. Lung treatment.
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Systemic Adaptive Immune Response
In addition, similar studies were conducted in the spleen to measure the systemic
adaptive immune response. All treatment groups showed elevated levels of CD3+ T
cells in the spleen in both single and secondary surgery groups. The number of T cells
then increases over time, with increases from 3 to seven days in each surgery group.
This increase is not seen with the GelMA treatment, further solidifying the proteins in the
decellularized matrix as the driving force of the T cell activation. In the same trend as
seen int the pervious study, CD4+ and CD8+ T cell populations were significantly
elevated in the decellularized matrix groups in comparison to the GelMA and control
groups at 3 and 7 days post-surgery for single surgery groups (Figure 16). Secondary
surgery groups see greater increases in T helper cells comparatively, and while reduced
the T helper cell activation is maintained through 14 days post secondary surgery in the
decellularized matrix treatments (Figure 17).
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7 Day

3 Day

1st Surgery Spleens

Figure 16: Changes in T cell populations in the spleen between single surgery
treatment groups (n=3) at 3 and 7 days post-surgery. Th signifies T helper cell groups
(CD4+) while Tc signifies cytotoxic T cell (CD8+) groups. # p<0.05 vs control, @ vs.
GelMA treatment, & vs. Liver treatment, % vs. Lung treatment.
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14 Day

7 Day

3 Day

2nd Surgery Spleens

Figure 17: Changes in T cell populations in the spleen between secondary surgery
treatment groups (n=3) at 3, 7 and 14 days post-surgery. Th signifies T helper cell
groups (CD4+) while Tc signifies cytotoxic T cell (CD8+) groups. # p<0.05 vs control,
@ vs. GelMA treatment, & vs. Liver treatment, % vs. Lung treatment.
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Systemically, there is a slight shift in the populations in the subsets of the T
helper cells. In the lymph node, the Th17 cell populations begin to reduce by 7 days
post initial surgery, however systemically these levels are maintained or even further
elevated in the 7 day time point in all treatment groups (Figure 18).

This can be

attributed to the delay in communication of adaptive immune cells and recruitment from
the spleen. In the secondary surgery groups, Th17 increases rapidly from day 3 post
surgery to day 7 post surgery before reducing as the phenotype shifts toward Th2 at 14
days (Figure 19).
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1st Surgery Spleens
3 Day

7 Day

Figure 18: Changes in T helper cell populations in the spleen between single
surgery treatment groups (n=3) at 3 and 7 days post-surgery. Following CD4%
selection, transcription factor staining for Tbet (TH1), Gata3 (TH2), RORγt (TH17)
and Foxp3 (Treg) identified T helper cell subsets. # p<0.05 vs control, @ vs.
GelMA treatment, & vs. Liver treatment, % vs. Lung treatment.
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2nd Surgery Spleens
3 Day

7 Day

14 Day

Figure 19: Changes in T helper cell populations in the spleen between secondary surgery treatment groups (n=3).
Following CD4% selection, transcription factor staining for Tbet (TH1), Gata3 (TH2), RORγt (TH17) and Foxp3 (Treg)
identified T helper cell subsets. # p<0.05 vs control, @ vs. GelMA treatment, & vs. Liver treatment, % vs. Lung
treatment.
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Conclusion
In vitro analysis showed the potential of antigen presentation of digested proteins
from decellularized matrices in the activation of CD4+ T helper cells and subsequent
proliferation. When applied to the in vivo setting through medullary cavity injection,
decellularized extracellular matrices produced an inflammatory reaction toward the M1
macrophage phenotype, that was mostly resolved over 7 days denoted by increases in
M2 macrophage phenotypes. When the animals were subjected to secondary surgeries
three weeks following their initial surgery, the inflammatory profile was increased, and
seemed to linger beyond the 7 day mark. While this could be attributed solely to the
second surgery itself, GelMA groups without decellularized matrices additives showed
attenuation of this inflammatory response, with M1 phenotype macrophages reducing to
near control levels in the bone marrow. The decellularized matrix treatment groups
showed a sustained M1 macrophage phenotype in the bone marrow cavity persisting for
14+ days following secondary surgery. This increase in sustained inflammation may be
due to a memory response from the adaptive immune system as similar peptides and
danger signals activate the CD4+ T helper cell response.
This trend was followed when T cell populations were identified in the bone
marrow as well as local lymph node. Secondary surgery groups showed persistent
elevated levels of CD4+ T helper cells in the bone marrow in comparison to the single
surgery groups. Right lymph node CD4+ T helper cell populations also showed
increases in the secondary surgery group in comparison to the primary surgery group,
as would be expected. Interestingly, CD8+ cytotoxic T cells showed elevated levels in
the secondary surgery groups when compared with the single surgery groups. This
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would not be expected, as CD8+ Cytotoxic T cells are generally activated by MHC I
antigen presentation, however Th1 subsets of CD4+ T cells produce interferon-γ which
stimulates the CD8+ activation in a positive feedback loop. The secondary surgery
groups showed elevated levels of Th1 populations in both the local (lymph node) as well
as systemic (spleen) CD4+ populations. In addition to elevated Th1 populations, the
secondary surgery groups had elevated levels of Th17 populations which greatly
influence the adaptive immune response. Th17 cells are one of the primary modulators
in autoimmunity, and increases in Th17 activity as well as IL-17 production denote an
extremely pro-inflammatory setting buoyed by antigen memory in CD4+ activation.
When subjected to multiple treatments of decellularized extracellular constructs, the
lengthened and heightened inflammatory response mediated by elevated Th1 and Th17
levels indicates that the repeated treatments of digested extracellular matrices provided
the antigens to influence the adaptive immune response, and provide a short-term
memory response. Overall, this suggests that when choosing the methodologies of
processing of decellularized matrices, further testing is needed to ensure that the
adaptive immune response to broken down peptides is minimized.
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